Metformin treatment improves PTSD symptoms, finds study

Written By :  Medha Baranwal
Medically Reviewed By :  Dr. Kamal Kant Kohli
Published On 2020-09-09 12:30 GMT   |   Update On 2020-09-10 07:05 GMT
Advertisement

New Orleans, LA: Metformin use may help in improving post-traumatic stress disorder (PTSD) symptoms among veterans, suggests a recent study in the ADA journal Diabetes.

There is a high prevalence of PTSD among US veterans for which there is no availability of effective psychotropic medications. About 25% of the veterans are diabetes patients for which metformin is the first-line treatment. Metformin is known to improve neurodegeneration outcomes, there is no evidence on the association between metformin use and PTSD-related symptom relief. This study by Shuian Liu from New Orleans, LA, and colleagues aimed to examine the association between metformin and a clinically meaningful reduction in PTSD symptoms (≥20 points reduction PTSD checklist for DSM-5 {PCL-5}) score)) among veterans with PTSD using data from Veterans Health Administration.

Advertisement

The participants were divided into two groups -- metformin cohort and control cohort. The metformin cohort was defined as first metformin use after a recorded PTSD diagnosis with a PCL-5 score ≥33 (i.e., clinical cut-score). The control cohort (never used metformin) was selected by propensity score 1:1 matching on the likelihood of initiating metformin. The association between metformin exposure and improvement in PCL-5 scores was assessed using multivariable Cox proportional regression. 

The study included a total of 7950 veterans with confirmed PTSD they were comparable on the baseline demographics and medical conditions between metformin and control PSM-matched cohorts with a median follow-up 1.2 years in both cohorts. 

Key findings of the study include:

  • The baseline PCL-5 score was 56.2±11.6 and 56.5±11.7 in metformin and control cohort, respectively.
  • The metformin-treated cohort was more likely to have a clinically meaningful reduction in PTSD symptoms (adjusted hazard ratio (aHR): 1.31), compared the control cohort.
  • Furthermore, patients on metformin ≥2 years were 22% more likely to reduce PTSD symptoms (aHR: 1.22), compared with metformin exposure <2 years.

Based on the findings the authors concluded that -- Metformin exposure may be beneficial to PTSD symptoms among veterans.

Abstract -- Association between Metformin Treatment and Improved Symptoms of Post-Traumatic Stress Disorder is published in American Diabetes Association (ADA) journal Diabetes.

DOI: https://doi.org/10.2337/db20-174-LB

Tags:    
Article Source : journal Diabetes

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News